In December 2005, the National Football League produced a scientific paper concluding that "professional football players do not sustain frequent repetive blows to the brain on a regular basis." That judgment, implausible even to a casual fan, also contradicted the opinion of a growing cadre of neuroscientists who worked in vain to convince the NFL that it was facing a deadly new scourge: a chronic brain disease that was driving an alarming number of players -- including some of the all-time greats -- to madness. In this conversation with Mark Fainaru-Wada, author of League of Denial, the NFL's apparent efforts to cover up and deny mounting evidence of the connection between football and brain damage over a period of nearly two decades are put into the spotlight.
League of Denial: The NFL, Concussions and the Battle for Truth
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In December 2005, the National Football League produced a scientific paper concluding that "professional football players do not sustain frequent repetive blows to the brain on a regular basis." That judgment, implausible even to a casual fan, also contradicted the opinion of a growing cadre of neuroscientists who worked in vain to convince the NFL that it was facing a deadly new scourge: a chronic brain disease that was driving an alarming number of players -- including some of the all-time greats -- to madness. In this conversation with Mark Fainaru-Wada, author of League of Denial, the NFL's apparent efforts to cover up and deny mounting evidence of the connection between football and brain damage over a period of nearly two decades are put into the spotlight.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?